Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of the Short-term Efficacy and Safety of Elaboration Transcatheter Arterial Chemoembolization (E-TACE) in Patients With Hepatocellular Carcinoma (HCC)

NCT06023147 is registered in ClinicalTrials.gov with Xuhua Duan as lead sponsor.

NCT NCT06023147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of the Short-term Efficacy and Safety of Elaboration Transcatheter Arterial Chemoembolization (E-TACE) in Patients With Hepatocellular Carcinoma (HCC)
Lead sponsor
Xuhua Duan
Phase
Not applicable
Overall status
Unknown status
Start date
September 10, 2023
Completion date
September 10, 2025
Enrollment
298 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma